Localization of the Gene for Congenital Dyserythropoietic Anemia Type I to a <1-cM Interval on Chromosome 15q15.1-15.3

• Published in: American journal of human genetics 1998-05, Vol.62 (5), p.1062-1069
• Main Authors: Tamary, Hannah, Shalmon, Lea, Shalev, Hanna, Halil, Albudar, Dobrushin, Dina, Ashkenazi, Noga, Zoldan, Meira, Resnitzky, Peretz, Korostishevsky, Michael, Bonne-Tamir, Batsheva, Zaizov, Rina
• Format: Article
• Language: English
• Subjects: Anemia; Anemia, Dyserythropoietic, Congenital - genetics; Bedouins; Biological and medical sciences; Chromosome 15; Chromosomes, Human, Pair 15; Congential dyserythropoietic anemia type 1; Female; Haplotypes; Hematologic and hematopoietic diseases; Humans; Linkage analysis; Linkage Disequilibrium; Male; Medical sciences; Mutation age; Other diseases. Hematologic involvement in other diseases; Pedigree; Sequence Analysis, DNA
• ISSN: 0002-9297; 1537-6605
• DOI: 10.1086/301834

Congenital dyserythropoietic anemias (CDA) are a rare group of red-blood-cell disorders of unknown etiology that are characterized by ineffective erythropoiesis, pathognomonic cytopathology of the nucleated red blood cells in the bone marrow, and secondary hemochromatosis. In CDA type I, bone-marrow electron microscopy reveals characteristic findings in erythroid precursors, including spongy heterochromatin and enlarged nuclear pores. Since the genetic basis of CDA type I is not evident, we used homozygosity and linkage mapping to localize the genetic defect responsible for CDA type I in 25 Bedouins from four large consanguineous families. We report the linkage of this disease to markers on chromosome 15 located at q15.1-q15.3. Fourteen markers within a 12-cM interval were typed in the relevant family members. Nine of the markers yielded maximum LOD scores of 1.625–12.928 at a recombination fraction of .00. Linkage disequilibrium was found only with marker D15S779. Haplotype analysis revealed eight different carrier haplotypes and highlighted the existence of a founder haplotype. Identification of historical crossover events further narrowed the gene location to between D15S779 and D15S778. The data suggest localization of the CDA type I gene within a 0.5-cM interval. The founder mutation probably occurred ≥400 years ago. Sequence analysis of the coding region of protein 4.2, the only known erythroid-specific gene in the locus, did not reveal any change in the CDA type I patients. Future analysis of this locus may lead to the identification of a gene essential to normal erythropoiesis.